| 09.09 06:35 | dpa-AFX: *MORGAN STANLEY HEBT IMCD AUF 'EQUAL-WEIGHT' - ZIEL 141 EUR |
| 09.09 06:35 | dpa-AFX: *MORGAN STANLEY RAISES IMCD TO 'EQUAL-WEIGHT' - PRICE TARGET 141 EUR |
| 03.09 05:38 | dpa-AFX: *JEFFERIES RAISES IMCD TO 'BUY' (HOLD) - PRICE TARGET 170 (140) EUR |
| 03.09 05:38 | dpa-AFX: *JEFFERIES HEBT IMCD AUF 'BUY' (HOLD) - ZIEL 170 (140) EUR |
| 29.08 17:45 | dpa-AFX: GNW-Adhoc: IMCD successfully issues a EUR 500 million rated bond |
| 02.08 07:00 | dpa-AFX: GNW-Adhoc: IMCD reports EBITA of EUR 270 million in the first half of 2024 |
| 10.06 07:00 | dpa-AFX: GNW-Adhoc: IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica |
| 14.05 17:00 | dpa-AFX: GNW-Adhoc: Shareholders IMCD N.V. adopt all resolutions at AGM |
| 26.04 07:00 | dpa-AFX: GNW-Adhoc: IMCD reports EBITA of EUR 127 million in the first three months of 2024 |
| 24.04 07:00 | dpa-AFX: GNW-Adhoc: IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma |
| 02.04 18:00 | dpa-AFX: GNW-Adhoc: IMCD publishes convocation for its upcoming Annual General Meeting |
| 27.03 07:00 | dpa-AFX: GNW-Adhoc: IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients |
| 20.03 07:00 | dpa-AFX: GNW-Adhoc: IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano |
| 13.03 06:37 | dpa-AFX: *BERENBERG STARTET IMCD MIT 'BUY' - ZIEL 183 EUR |
| 13.03 06:37 | dpa-AFX: *BERENBERG STARTS IMCD WITH 'BUY' - PRICE TARGET 183 EUR |
| 06.03 05:42 | dpa-AFX: *JPMORGAN HEBT IMCD AUF 'OVERWEIGHT' (UNDERWEIGHT) - ZIEL 188 (117) EUR |
| 06.03 05:42 | dpa-AFX: *JPMORGAN RAISES IMCD TO 'OVERWEIGHT' (UNDERWEIGHT) - PRICE TARGET 188 (117) EUR |
| 04.03 05:13 | dpa-AFX: *JEFFERIES CUTS IMCD TO 'HOLD' (BUY) - PRICE TARGET 165 (178) EUR |
| 04.03 05:13 | dpa-AFX: *JEFFERIES SENKT IMCD AUF 'HOLD' (BUY) - ZIEL 165 (178) EUR |
| 01.03 07:02 | dpa-AFX: GNW-Adhoc: IMCD announces dividend proposal and Supervisory Board nominations for reappointment |
|
|
